Barriers and Facilitators to the Deprescribing of Nonbenzodiazepine Sedative Medications Among Older Adults
Author(s) -
Jennifer L. Kuntz,
Louis Kouch,
Daniel Christian,
Preston L Peterson,
Inga Gruß
Publication year - 2018
Publication title -
the permanente journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.445
H-Index - 30
eISSN - 1552-5775
pISSN - 1552-5767
DOI - 10.7812/tpp/17-157
Subject(s) - deprescribing , medicine , discontinuation , beers criteria , sedative , polypharmacy , intervention (counseling) , pharmacist , health care , psychiatry , nursing , geriatrics , intensive care medicine , pharmacy , economics , economic growth
Nonbenzodiazepine sedative-hypnotic medications, or "Z-drugs," are commonly used to treat insomnia among older adults (≥ 65 years), despite a lack of evidence of long-term effectiveness and evidence linking long-term use with poor outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom